Abstract Submission
Please download the abstract submission form at the bottom of the screen and send the completed form to jsp2026-abs@congre.co.jp by E-mail
Information required for abstract submission
The non-Japanese first author from international institutions are not required to be a member of the society.
Authors who submit abstracts from institutions in Japan must be a member of the Japanese Society of Pathology (except for undergraduate students giving poster presentations). (Those who are applying for membership, please enter "99" in the "Membership Number" box.)
Inquiries regarding membership can be obtained at the Secretariat Office of the Japanese Society of Pathology. The details of the contact can be found at the bottom of this page.
Abstract submission
| Session | Deadline |
|---|---|
Public offering session
|
Tuesday, September 2 2025 – Thursday, October 30, 2025 |
|
Tuesday, September 2 2025 – Thursday, October 30, 2025 |
Presentation style
- Oral presentation
- Poster presentation
- Poster presentation（Undergraduate students）
- Poster presentation (Trainees)
- Poster presentation (Postgraduate students ⋅ Residents)
- Oral presentation (Public offering session)
- Symposium
- Workshop
Please note that we may ask you to present in a different presentation style from your preferred at the time of abstract acceptance.
Keywords *required
Keywords 1 *
| 1 | Diagnostic pathology ⋅ Human pathology |
|---|---|
| 2 | Experimental pathology |
| 3 | Others |
Keywords 2 *
| 1 | Interdisciplinary pathology |
|---|---|
| 2 | Systemic diseases |
| 3 | Oral cavity ⋅ Head and neck ⋅ Salivary glands |
| 4 | Heart |
| 5 | Vessels |
| 6 | Respiratory tract |
| 7 | Mediastinum ⋅ Thymus |
| 8 | Serosal membranes ⋅ Mesothelium ⋅ Somatic cavity |
| 9 | Upper gastrointestinal tract |
| 10 | Lower gastrointestinal tract |
| 11 | Liver |
| 12 | Biliary system |
| 13 | Pancreas |
| 14 | Breast |
| 15 | Endocrine organs |
| 16 | Urinary system |
| 17 | Male reproductive organs |
| 18 | Female reproductive organs |
| 19 | Placenta and perinatal pathology |
| 20 | Pediatric pathology |
| 21 | Central nervous system |
| 22 | Peripheral nervous system |
| 23 | Bone and soft tissue ⋅ Locomotor organs |
| 24 | Blood ⋅ Bone marrow |
| 25 | Lymph nodes |
| 26 | Spleen |
| 27 | Skin |
| 28 | Sensory organs |
| 29 | Others |
Keywords 3-1 *
| 1 | Neoplastic diseases |
|---|---|
| 2 | Inflammatory diseases |
| 3 | Infectious diseases |
| 4 | Chronic progressive diseases |
| 5 | Circulatory failure ⋅ Circulatory disturbance |
| 6 | Metabolic disorder ⋅ Degenerative disorder |
| 7 | Transplantation pathology |
| 8 | Intractable and rare diseases |
| 9 | Congenital disorder ⋅ Developmental anomaly |
| 10 | Radiation injury |
| 11 | Autopsy |
| 12 | Cytodiagnosis |
| 13 | Intraoperative consultation |
| 14 | Differential diagnosis |
| 15 | Immunohistochemistry ⋅ Diagnostic molecular pathology |
| 16 | Classification of Diseases |
| 17 | Evaluation of treatment effects ⋅ Therapeutic strategies |
| 18 | Epidemiology ⋅ Statistics |
| 19 | Image analysis ⋅ AI ⋅ Digital pathology |
| 20 | Information technology ⋅ Bioinformatics |
| 21 | Education ⋅ Medical staff |
| 22 | Quality control |
| 23 | Work-life balance |
| 24 | Chromosomal abnormality ⋅ Hereditary diseases |
| 25 | Animal disease models |
| 26 | Genetic risks ⋅ Environmental factors |
| 27 | Genetic mutation ⋅ Carcinogenesis |
| 28 | Gene expression ⋅ Epigenetics |
| 29 | Signal transduction ⋅ Cell proliferation ⋅ Cell cycle |
| 30 | Cell death ⋅ Cell damage ⋅ Senescence |
| 31 | Invasion and metastasis |
| 32 | Cancer microenvironment ⋅ Cancer stem cells |
| 33 | Cancer cellular characteristics |
| 34 | Cancer immunology |
| 35 | Diagnostic markers ⋅ Tumor markers ⋅ New therapies |
| 36 | Cell biology ⋅ Molecular imaging |
| 37 | Cell differentiation ⋅ Regenerative medicine |
| 38 | Development and developmental abnormalities |
| 39 | Immunity ⋅ Inflammation |
| 40 | Autoimmunity ⋅ Autoinflammation |
| 41 | Novel technology ⋅ Experimental technique |
| 42 | Spatial transcriptome ⋅ Single cell analysis |
| 43 | Medical safety |
| 44 | Others |
Keywords 3-2 for Second Choice (The same keywords as Keywords 3-1)
- Title
The title must be written in English.
Maximum number of letters: 100
*Titles with more than 100 letters cannot be registered. - Abstract (main text)
Abstract will be accepted in English only.
Maximum number of letters: 1040 - Co-author(s) / affiliation(s)
Co-author(s): up to 10 persons including the first author Affiliation(s): up to 10 institutions List of abbreviations used for affiliations: here
- Selection of abstracts
Submitted abstracts will be peer-reviewed, and acceptance and presentation style will be decided by the program committee. Notifications of accepted abstract will be sent by e-mail to the authors.
Abstract Submission Form
Please download the abstract submission form and send the completed form to jsp2026-abs@congre.co.jp by E-mail.
Inquiries regarding abstract submission
Submission Desk of the 115th Annual Meeting of the Japanese Society of Pathology
c/o Congrès Inc.
E-mail: jsp2026-abs@congre.co.jp